Media Assistance:
 Michael Purdy Senior Medical Sciences Writer purdym@wustl.edu (314) 286-0122 |
The Renal Division at Washington University has one of the oldest, largest and most respected dialysis practices in the United States. Many of the original studies performed that define the way dialysis is practiced throughout the world were done here. The division, part of the Department of Internal Medicine, was created as a separate entity in 1956. Its physicians have reputations that are international in scope. The division has been recognized as one of the best by U.S. News & World Report every year since ratings began.
The Chromalloy American Kidney Center is owned and operated by Washington University School of Medicine and is the largest kidney dialysis center in the St. Louis region. It is also the largest of five dialysis units in the St. Louis area that are staffed by the University's renal division, and it is a major base for the teaching and research activities of the division.
For more information about dialysis or renal disease, check out the news stories and experts below. Related medical links may be found to the right.
| Faculty Experts: |
|
Showing 1 Dialysis Experts. |
|
| Keith Hruska Professor of nephrology (http://mednews.wustl.edu/sb/page/normal/714.html) Hruska is a leader in studies of the links between the kidney and the skeleton, which can cause devastating side effects for patients with chronic kidney disease (CKD). Kidneys and bones produce factors that support each other's development and maintenance, and when CKD damages the kidney and reduces ... Expertise: kidney, chronic kidney disease, bone, bone weakening, adynamic bone disorder, secondary hyparathyroidism, bone morphogenetic protein Media assistance: (314) 286-0122 / purdym@wustl.edu |
|
Showing 1 Dialysis Experts. |
|
| News Stories & Tip Sheets: |
|
Showing Dialysis Stories 1 through 3 of 18. - Show More |
|
| Igniting a recall Quick thinking by WUSM physician leads to international investigation (http://mednews.wustl.edu/news/page/normal/11693.html) May 1, 2008 -- In early January, two patients undergoing kidney dialysis at St. Louis Children's Hospital had sudden life-threatening allergic reactions that caused their eyes, lips and tongues to swell, raised their heart rates and dropped their blood pressures dangerously low. After the dialysis staff treated the children with medication that relieved the symptoms, they called infectious diseases specialist Alexis Elward, who sprung into action to help determine the cause. Little did she know it would spark an international investigation into a common blood thinner and a recall of the drug from the market. |
| Avoiding vascular calcification Readily available treatment could help prevent heart disease in kidney patients (http://mednews.wustl.edu/news/page/normal/11403.html) April 17, 2008 -- The estimated 19 million Americans living with chronic kidney disease (CKD) face a high risk of death from cardiovascular disease, usually related to high levels of blood phosphate. Now researchers at the School of Medicine have demonstrated that high blood phosphate directly stimulates calcification of blood vessels and that phosphate-binding drugs can decrease vascular calcification. |
| Fighting a 'devastating illness' $5.7 million to fund new kidney disease research center (http://mednews.wustl.edu/news/page/normal/9811.html) Aug. 6, 2007 -- A $5.7 million grant will establish a new center for kidney disease research at the School of Medicine. Directed by Marc R. Hammerman, the Chromalloy Professor of Renal Diseases in Medicine, the center will investigate the underlying causes of kidney disease to speed the development of new treatments. The center's funding comes from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), one of the National Institutes of Health (NIH). |
|
Showing Dialysis Stories 1 through 3 of 18. - Show More |
|
| Related News Clips: |
|
Showing Dialysis Clips 1 through 5 of 9. - Show More |
 Show More Dialysis Clips |
|
| Cutting Phosphate May Protect Kidney Patients From Heart Trouble
The Washington Post and 11 others April 24, 2008 -- Readily available phosphate-binding drugs could help prevent heart disease in people with chronic kidney disease, a new study in the the Journal of the American Society of Nephrology finds. WUSTL researchers led by pediatric nephrology specialist Keith Hruska and pediatrics instructor Suresh Mathew comment. |
| Dr. Louis Arrone discusses new research showing some obesity may be caused by virus
NBC Today Show Aug. 23, 2007 -- Matt Lauer hosts this segment and speaks with nutrition experts about new research that suggests that some types of obesity may be linked to a common virus. WUSTL nutrition researcher Samuel Klein is one of the experts commenting. |
| Study Urges Caution on Anemia Drug Use
Associated Press Online and 55 others April 18, 2007 -- A flawed Medicare payment plan encourages aggressive use of a risky and costly anti-anemia drug on many kidney dialysis patients, say researchers who warn the system should be changed. In an accompanying editorial in JAMA, WUSTL renal expert Daniel Coyne said kidney doctors who work with dialysis centers may not know they are "making dubious dosing decisions" because they sign multipage standing orders and turn over anemia management to chain employees. |
| Doctors' Ties to Drug Makers Are Put on Close View
The New York Times and 3 others March 21, 2007 -- A 2002 survey found that more than 80 percent of the doctors on panels that write clinical practice guidelines had financial ties to drug makers. This article looks at the serious conflict of interest problem that arises when drug companies pay for drug research. WUSTL professor and kidney specialist Daniel Coyne recently wrote an editorial in an influential journal decrying guidelines written last year by the kidney foundation that encourage doctors to use more of Amgen's drugs to treat anemia in kidney patients despite studies showing that increased use led to more deaths. |
| Kidney ills linked to metabolic syndrome
United Press International March 12, 2007 -- A WUSTL study of kidney dialysis patients found nearly 70 percent had metabolic syndrome, considered a predictor of cardiovascular disease. Study leader and WUSTL postdoctoral fellow Daniel Young comments. The study was published in Hemodialysis International. |
|
Related Information Related Links:
Related Groups:
|